Vivian Y. Shi

High Impact

Researcher

UAMS

Last publication 2025 Last refreshed 2026-05-16

faculty

40 h-index 408 pubs 5,356 cited

Research Areas

Links

ORCID Research Group

OverviewAI-generated summary

Vivian Y. Shi's research focuses on dermatological conditions, particularly atopic dermatitis and hidradenitis suppurativa. She has investigated the efficacy and safety of various treatments for moderate-to-severe atopic dermatitis, including the JAK inhibitor delgocitinib and the pan-JAK inhibitor abrocitinib, in clinical trials. Her work also extends to the role of the skin barrier and moisturization in skin health and repair, as well as the impact of *Staphylococcus aureus* on atopic dermatitis. Shi has also contributed to the understanding of hidradenitis suppurativa through systematic reviews and meta-analyses of treatments like infliximab.

Her research group is active in exploring new therapeutic approaches and understanding the underlying mechanisms of these skin diseases. Shi's publication record includes work on the skin barrier, novel moisturizers, and the development of point-of-care diagnostics. Her scholarship metrics indicate a significant research output, with 408 publications and an h-index of 39. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Jay Kincannon, Edita M. Newton, Henry Bishop, and Charlotte Y. Jeong.

Metrics

h-index: 40
Publications: 408
Citations: 5,356

Selected Publications

Ustekinumab in Hidradenitis Suppurativa: A Systematic Review and Meta-analysis (2024)

7 citations DOI OpenAlex
Expert Practices in Hidradenitis Suppurativa Flare Management: A Cross-Sectional Survey Study (2024)

8 citations DOI OpenAlex
Top cited articles in dissecting cellulitis of the scalp: A bibliometric analysis (2023)

6 citations DOI OpenAlex
Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm (2023)

19 citations DOI OpenAlex
Efficacy of medical treatments for pediatric hidradenitis suppurativa: A systematic review (2023)

14 citations DOI OpenAlex
Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry (2023)

9 citations DOI OpenAlex
Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa—Part II: Procedural and Wound Care Therapies (2023)

7 citations DOI OpenAlex
Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies (2023)

14 citations DOI OpenAlex
Trimethoprim/sulfamethoxazole and cephalexin combination therapy in hidradenitis suppurativa patients: A series of 16 cases (2023)

7 citations DOI OpenAlex
Efficacy of procedural treatments for pediatric hidradenitis suppurativa: A systematic review (2023)

9 citations DOI OpenAlex
Expert consensus on priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa: a Delphi consensus study (2023)

8 citations DOI OpenAlex
Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review (2023)

17 citations DOI OpenAlex
Low Rates of Psychosocial Screening and Lifestyle Counseling in Hidradenitis Suppurativa Patients in the USA (2023)

6 citations DOI OpenAlex
Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data (2022)

11 citations DOI OpenAlex
Optimizing hidradenitis suppurativa clinic visits: Patient perspectives (2022)

6 citations DOI OpenAlex